Get the Stockscreener App
0.74
4.06%
-0.0313
Gossamer Bio Inc Stock (GOSS) Forecast
The Gossamer Bio Inc (GOSS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.4018, representing a +224.57% increase from the current price of $0.74. The highest analyst price target is $4.7451, and the lowest is $0.0585.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GOSS Price Target
Average 5.2308
(+606.86% Upside)
Is Gossamer Bio Inc (GOSS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.35 | Neutral |
| STOCH(9,6) | 40.59 | Neutral |
| STOCHRSI(14) | 85.21 | Sell |
| MACD(12,26) | -0.1091 | Buy |
| ADX(14) | 41.64 | Sell |
| William %R | -54.36 | Neutral |
| CCI(14) | -3.0565 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7152
Buy
|
0.7452
Sell
|
| MA20 |
0.8087
Sell
|
0.8231
Sell
|
| MA50 |
1.1129
Sell
|
0.9617
Sell
|
| MA100 |
1.0204
Sell
|
0.9945
Sell
|
| MA200 |
0.9505
Sell
|
1.0777
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, GOSS could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on GOSS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.35 indicates that GOSS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 40.59 indicates that GOSS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 85.21 indicates that GOSS is oversold. This suggests that GOSS price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 41.64 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -3.0565 indicates that GOSS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term GOSS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Gossamer Bio Inc financial reports and earnings history, Gossamer Bio Inc (GOSS) stock could reach $17.72 by 2030, $12.78 by 2040 and $33.98 by 2050. See the projected annual prices until 2050 of the Gossamer Bio Inc stock below:
- Gossamer Bio Inc (GOSS) is expected to reach an average price of $4.0519 in 2035, with a high prediction of $4.7782 and a low estimate of $4.1239. This indicates an $447.55% rise from the last recorded price of $0.74.
- Gossamer Bio Inc (GOSS) stock is projected to chart a bullish course in 2040, with an average price target of $12.25, representing an $1,555% surge from its current level. The forecast ranges from a conservative $12.45 to a sky-high $12.78.
- Our analysts predict Gossamer Bio Inc (GOSS) to jump 1,796% by 2045, soaring from $13.59 to an average price of $14.03, potentially reaching $13.54. While $13.59 is the low estimate, the potential upside is significant.
- Gossamer Bio Inc (GOSS) stock is expected to climb by 2050, reaching an average of $33.69, a $4,453% jump from its current level. However, a wide range of estimates exists, with high and low targets of $33.98 and $34.30, respectively, highlighting the market's uncertainty.
Gossamer Bio Inc Stock (GOSS) Year by Year Forecast
Gossamer Bio Inc Stock (GOSS) Price Forecast for 2024
Our forecast for GOSS stock price in 2024 now indicates an average price target of $4.875 with a high forecast of $9.6916 and a low forecast of $0.0585. The average prediction reflects an increase of +558.79% from the last recorded price of $0.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $3.5951 | $0.0585 | $4.7451 | +385.83% |
| July, 2024 | $1.794 | $0.7905 | $4.5369 | +142.44% |
| August, 2024 | $0.3388 | $0.2124 | $3.0858 | -54.22% |
| September, 2024 | $4.0583 | $0.277 | $4.8433 | +448.43% |
| October, 2024 | $0.7777 | $1.3181 | $5.0301 | +5.10% |
| November, 2024 | $5.8844 | $1.4709 | $6.1194 | +695.19% |
| December, 2024 | $9.0716 | $3.4362 | $9.6916 | +1,126% |
Gossamer Bio Inc Stock (GOSS) Price Forecast for 2025
Gossamer Bio Inc Stock (GOSS) is expected to reach an average price of $5.6173 in 2025, with a high prediction of $10.40 and a low estimate of $0.8316. This indicates an +659.10% rise from the last recorded price of $0.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.0595 | $1.1881 | $10.40 | +43.17% |
| February, 2025 | $3.0323 | $2.3277 | $2.1623 | +309.77% |
| March, 2025 | $3.0802 | $1.5688 | $1.3952 | +316.24% |
| April, 2025 | $5.6612 | $3.5534 | $5.4098 | +665.03% |
| May, 2025 | $3.1691 | $3.9391 | $5.4845 | +328.26% |
| June, 2025 | $1.0619 | $1.9019 | $2.5255 | +43.51% |
| July, 2025 | $2.683 | $3.0202 | $1.9548 | +262.57% |
| August, 2025 | $1.5559 | $1.9209 | $1.7194 | +110.25% |
| September, 2025 | $0.8387 | $1.0823 | $0.8877 | +13.34% |
| October, 2025 | $1.2198 | $0.8316 | $0.7431 | +64.83% |
| November, 2025 | $1.4326 | $1.3362 | $1.0044 | +93.60% |
| December, 2025 | $5.2337 | $2.319 | $3.7937 | +607.25% |
Gossamer Bio Inc Stock (GOSS) Price Forecast for 2026
The predicted value for Gossamer Bio Inc (GOSS) in 2026 is set at an average of $2.2833. Estimates vary from a peak of $4.3541 to a trough of $0.2125, indicating an +208.56% surge from the present price of $0.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.3065 | $4.5565 | $4.3541 | +481.96% |
| February, 2026 | $1.6394 | $2.8294 | $4.1247 | +121.54% |
| March, 2026 | $2.5022 | $2.7322 | $2.5058 | +238.14% |
| April, 2026 | $1.6533 | $2.2272 | $2.0904 | +123.42% |
| May, 2026 | $2.8561 | $2.9961 | $2.3797 | +285.97% |
| June, 2026 | $3.249 | $2.9008 | $2.8276 | +339.05% |
| July, 2026 | $3.0501 | $3.5036 | $3.0654 | +312.17% |
| August, 2026 | $2.5929 | $2.9829 | $2.7147 | +250.39% |
| September, 2026 | $2.984 | $3.0511 | $2.7458 | +303.24% |
| October, 2026 | $2.6168 | $3.2868 | $3.2204 | +253.62% |
| November, 2026 | $0.6897 | $0.9497 | $1.675 | -6.80% |
| December, 2026 | $2.2593 | $0.2125 | $3.7793 | +205.31% |
Gossamer Bio Inc Stock (GOSS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Gossamer Bio Inc (GOSS) is $3.4267, with a high forecast of $6.8522 and a low forecast of $0.0011. This indicates an +363.06% increase from the last price of $0.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.6664 | $1.6128 | $4.1646 | +260.33% |
| February, 2027 | $1.7436 | $1.2936 | $3.8468 | +135.62% |
| March, 2027 | $1.2225 | $0.3525 | $1.9853 | +65.20% |
| April, 2027 | $2.5796 | $0.5843 | $3.5896 | +248.60% |
| May, 2027 | $0.4132 | $0.055 | $2.5714 | -44.16% |
| June, 2027 | $0.8857 | $0.2239 | $1.1239 | +19.69% |
| July, 2027 | $0.2129 | $0.0011 | $1.3325 | -71.23% |
| August, 2027 | $0.58 | $0.2047 | $1.8665 | -21.62% |
| September, 2027 | $0.311 | $0.801 | $0.9868 | -57.97% |
| October, 2027 | $0.9739 | $0.8592 | $0.8439 | +31.61% |
| November, 2027 | $0.2933 | $0.0367 | $1.5933 | -60.37% |
| December, 2027 | $6.7622 | $0.5349 | $6.8522 | +813.81% |
Gossamer Bio Inc Stock (GOSS) Price Forecast for 2028
In 2028, Gossamer Bio Inc (GOSS) is projected to reach an average price of $5.1826, with a high projection of $8.2108 and a low estimate of $2.1544. This indicates an +600.35% rise from the last price of $0.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.4294 | $6.214 | $8.2108 | +903.97% |
| February, 2028 | $5.3665 | $4.9747 | $8.1911 | +625.20% |
| March, 2028 | $4.7954 | $3.8637 | $7.1233 | +548.03% |
| April, 2028 | $2.8726 | $2.6308 | $5.0872 | +288.19% |
| May, 2028 | $3.8485 | $2.1544 | $3.678 | +420.06% |
| June, 2028 | $3.5113 | $3.4831 | $3.3749 | +374.50% |
| July, 2028 | $2.9542 | $2.7943 | $2.9144 | +299.21% |
| August, 2028 | $3.6352 | $3.1924 | $3.2188 | +391.25% |
| September, 2028 | $3.6081 | $3.5799 | $3.5417 | +387.58% |
| October, 2028 | $3.0909 | $3.2309 | $3.3863 | +317.69% |
| November, 2028 | $2.832 | $2.952 | $2.8288 | +282.70% |
| December, 2028 | $2.6948 | $2.7266 | $2.7602 | +264.17% |
Gossamer Bio Inc Stock (GOSS) Price Forecast for 2029
The 2029 price forecast for Gossamer Bio Inc Stock (GOSS) is $8.9346 on average, with a high prediction of $17.86 and a low estimate of $0.00441. This represents an +1,107% increase from the previous price of $0.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.2359 | $2.3259 | $2.3831 | +202.15% |
| February, 2029 | $2.3188 | $2.2641 | $2.2588 | +213.35% |
| March, 2029 | $2.1712 | $2.1952 | $2.152 | +193.41% |
| April, 2029 | $2.1984 | $2.206 | $2.1391 | +197.08% |
| May, 2029 | $2.0117 | $2.0415 | $2.1609 | +171.85% |
| June, 2029 | $1.4424 | $1.505 | $1.6337 | +94.92% |
| July, 2029 | $1.1287 | $1.1748 | $1.1166 | +52.53% |
| August, 2029 | $0.8923 | $0.9321 | $0.9494 | +20.58% |
| September, 2029 | $0.1851 | $0.4051 | $0.7505 | -74.98% |
| October, 2029 | $0.1738 | $0.0302 | $0.322 | -76.51% |
| November, 2029 | $0.1453 | $0.00441 | $0.2456 | -80.37% |
| December, 2029 | $18.14 | $0.0537 | $17.86 | +2,351% |
Gossamer Bio Inc Stock (GOSS) Price Forecast for 2030
Gossamer Bio Inc Stock (GOSS) is expected to reach an average price of $14.85 in 2030, with a high forecast of $21.23 and a low forecast of $8.4733. This signifies an +1,907% surge from the last price of $0.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $16.59 | $18.17 | $17.72 | +2,142% |
| February, 2030 | $15.98 | $15.80 | $14.95 | +2,060% |
| March, 2030 | $17.65 | $16.60 | $15.64 | +2,285% |
| April, 2030 | $14.81 | $18.07 | $16.71 | +1,902% |
| May, 2030 | $18.09 | $15.65 | $17.75 | +2,344% |
| June, 2030 | $15.76 | $19.40 | $17.98 | +2,029% |
| July, 2030 | $8.959 | $11.86 | $13.02 | +1,111% |
| August, 2030 | $17.42 | $8.4733 | $15.49 | +2,255% |
| September, 2030 | $18.71 | $17.81 | $17.52 | +2,428% |
| October, 2030 | $17.63 | $17.70 | $18.41 | +2,283% |
| November, 2030 | $21.77 | $17.88 | $19.39 | +2,842% |
| December, 2030 | $21.23 | $21.58 | $21.23 | +2,769% |
1.62%
0.15%
Cap:
|
Volume (24h):